Use of bioconjugation with cytochrome P450 enzymes

被引:17
|
作者
Ducharme, Julie [1 ]
Auclair, Karine [1 ]
机构
[1] McGill Univ, Dept Chem, 801 Sherbrooke St West, Montreal, PQ H3A 0B8, Canada
来源
基金
加拿大自然科学与工程研究理事会;
关键词
Bioconjugation; Biocatalysis; Biosensor; Photoaffinity; Allostery; Immobilization; MECHANISM-BASED INACTIVATION; SUBSTRATE RECOGNITION SITE; DRUG-DRUG INTERACTIONS; MULTIPLE BINDING-SITES; ACTIVITY-BASED PROBES; 3A4; ACTIVE-SITE; ELECTRON-TRANSFER; HETEROTROPIC COOPERATIVITY; P450; REDUCTASE; HEME DOMAIN;
D O I
10.1016/j.bbapap.2017.06.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bioconjugation, defined as chemical modification of biomolecules, is widely employed in biological and biophysical studies. It can expand functional diversity and enable applications ranging from biocatalysis, biosensing and even therapy. This review summarizes how chemical modifications of cytochrome P450 enzymes (P450s or CYPs) have contributed to improving our understanding of these enzymes. Genetic modifications of P450s have also proven very useful but are not covered in this review. Bioconjugation has served to gain structural information and investigate the mechanism of P450s via photoaffinity labeling, mechanism-based inhibition (MBI) and fluorescence studies. P450 surface acetylation and protein cross-linking have contributed to the investigation of protein complexes formation involving P450 and its redox partner or other P450 enzymes. Finally, covalent immobilization on polymer surfaces or electrodes has benefited the areas of biocatalysis and biosensor design. This article is part of a Special Issue entitled: Cytochrome P450 biodiversity and biotechnology, edited by Erika Plettner, Gianfranco Gilardi, Luet Wong, Vlada Urlacher, Jared Goldstone.
引用
收藏
页码:32 / 51
页数:20
相关论文
共 50 条
  • [21] Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans
    Moessner, Lone D.
    Schmitz, Andrea
    Theurillat, Regula
    Thormann, Wolfgang
    Mevissen, Meike
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2011, 72 (11) : 1505 - 1513
  • [22] Impact of Mutant P450 Oxidoreductase on Metabolic Capacity of Cytochrome P450 Enzymes
    Tomalik-Scharte, Dorota
    Maiter, Dominique
    Kirchheiner, Julia
    Ivison, Hannah
    Fuhr, Uwe
    Arlt, Wiebke
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 104 (06) : 502 - 503
  • [24] Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5 enzymes
    Shimada, T
    Mernaugh, RL
    Guengerich, FP
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 435 (01) : 207 - 216
  • [25] Unlocking the Clinical Significance of Cytochrome P450 Enzymes
    Hadia, Rajesh
    Singh, Vishal
    Solanki, Nidhi
    Sharma, Shiwanand
    Saggu, Varunsingh
    Sajan, Cyril
    Trivedi, Rahul
    Kardani, Sunil
    Baile, Sunil
    Rajput, Hemraj Singh
    Maheshwari, Rajesh
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2024, 14 (01) : 30 - 38
  • [26] Inhibition of Cytochrome P450 Enzymes by Quinones and Anthraquinones
    Sridhar, Jayalakshmi
    Liu, Jiawang
    Foroozesh, Maryam
    Stevens, Cheryl L. Klein
    CHEMICAL RESEARCH IN TOXICOLOGY, 2012, 25 (02) : 357 - 365
  • [27] Effects of icaritin on cytochrome P450 enzymes in rats
    Liang, Dong-Lou
    Zheng, Shuang-li
    PHARMAZIE, 2014, 69 (04): : 301 - 305
  • [28] Cytochrome P450 - Versatile enzymes for medicine and biotechnology
    Urlacher V.B.
    Bernhardt R.
    BIOspektrum, 2019, 25 (7) : 715 - 718
  • [29] Steroidogenic cytochrome P450 enzymes as drug target
    Kim, Changmin
    Jeong, Eunseo
    Lee, Yoo-bin
    Kim, Donghak
    TOXICOLOGICAL RESEARCH, 2024, 40 (03) : 325 - 333
  • [30] Cancer treatment and pharmacogenetics of cytochrome P450 enzymes
    van Schaik, RHN
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (06) : 513 - 522